Last reviewed · How we verify
PF-07202954 Repeat Dose (pf-07202954-repeat-dose)
At a glance
| Generic name | pf-07202954-repeat-dose |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 1 |
Approved indications
Common side effects
- Conjunctival haemorrhage
- Application site irritation
- Procedural pain
- Menstruation irregular
- Frequent bowel movements
- Nausea
- Lymph node palpable
- Paraesthesia
- Somnolence
- Dysmenorrhoea
- Respiratory symptom
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |